다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Fortress Biotech Inc (FBIO)
Fortress Biotech Inc (FBIO) 뉴스

FBIO

Fortress Biotech (FBIO)

Fortress Biotech Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:FBIO

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/11/15	06:10	GlobeNewswire Inc.	Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights	NASDAQ:FBIO	Fortress Biotech Inc
2024/11/15	06:05	GlobeNewswire Inc.	Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights	NASDAQ:FBIO	Fortress Biotech Inc
2024/11/13	06:01	GlobeNewswire Inc.	Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights	NASDAQ:FBIO	Fortress Biotech Inc
2024/11/12	22:30	GlobeNewswire Inc.	Mustang Bio Receives Positive Listing Determination from Nasdaq	NASDAQ:FBIO	Fortress Biotech Inc
2024/11/07	22:30	GlobeNewswire Inc.	Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma	NASDAQ:FBIO	Fortress Biotech Inc
2024/11/04	21:00	GlobeNewswire Inc.	Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea	NASDAQ:FBIO	Fortress Biotech Inc
2024/10/25	21:30	GlobeNewswire Inc.	Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference	NASDAQ:FBIO	Fortress Biotech Inc
2024/10/25	03:10	GlobeNewswire Inc.	Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds	NASDAQ:FBIO	Fortress Biotech Inc
2024/10/09	21:30	GlobeNewswire Inc.	Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit	NASDAQ:FBIO	Fortress Biotech Inc
2024/10/03	21:30	GlobeNewswire Inc.	Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference	NASDAQ:FBIO	Fortress Biotech Inc
2024/09/26	21:30	GlobeNewswire Inc.	Fortress Biotech to Participate in October 2024 Investor Conferences	NASDAQ:FBIO	Fortress Biotech Inc
2024/09/20	21:30	GlobeNewswire Inc.	Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements	NASDAQ:FBIO	Fortress Biotech Inc
2024/09/09	21:30	GlobeNewswire Inc.	Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference	NASDAQ:FBIO	Fortress Biotech Inc
2024/09/04	21:30	GlobeNewswire Inc.	Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:FBIO	Fortress Biotech Inc
2024/09/04	21:15	GlobeNewswire Inc.	Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:FBIO	Fortress Biotech Inc
2024/09/03	21:30	GlobeNewswire Inc.	Avenue Therapeutics to Participate in Upcoming Investor Conferences	NASDAQ:FBIO	Fortress Biotech Inc
2024/08/14	05:05	GlobeNewswire Inc.	Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights	NASDAQ:FBIO	Fortress Biotech Inc
2024/08/13	05:01	GlobeNewswire Inc.	Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights	NASDAQ:FBIO	Fortress Biotech Inc
2024/08/10	05:05	GlobeNewswire Inc.	Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights	NASDAQ:FBIO	Fortress Biotech Inc
2024/08/07	05:01	GlobeNewswire Inc.	Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024	NASDAQ:FBIO	Fortress Biotech Inc
2024/07/25	21:30	GlobeNewswire Inc.	Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027	NASDAQ:FBIO	Fortress Biotech Inc
2024/07/12	05:05	GlobeNewswire Inc.	Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors	NASDAQ:FBIO	Fortress Biotech Inc
2024/07/06	05:05	GlobeNewswire Inc.	Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock	NASDAQ:FBIO	Fortress Biotech Inc
2024/06/22	05:01	GlobeNewswire Inc.	Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:FBIO	Fortress Biotech Inc
2024/06/20	21:30	GlobeNewswire Inc.	Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference	NASDAQ:FBIO	Fortress Biotech Inc
2024/06/20	21:00	GlobeNewswire Inc.	Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:FBIO	Fortress Biotech Inc
2024/06/17	21:30	GlobeNewswire Inc.	Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy	NASDAQ:FBIO	Fortress Biotech Inc
2024/05/16	21:30	GlobeNewswire Inc.	Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)	NASDAQ:FBIO	Fortress Biotech Inc
2024/05/16	21:00	GlobeNewswire Inc.	Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase	NASDAQ:FBIO	Fortress Biotech Inc
2024/05/16	05:15	GlobeNewswire Inc.	Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights	NASDAQ:FBIO	Fortress Biotech Inc

검색 관련기사 보기:NASDAQ:FBIO

1 2 3 4 5 6 7 8 9 10 다음 >>

Bank of America

Health Care Select Sector

US Dollar vs Yen

Invesco QQQ Trust Series 1

US Dollar vs Euro

Energy Select Sector SPDR

Gold vs US Dollar

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관